Novavax Inc: * EMA – PRAC HAS CONCLUDED THAT MYOCARDITIS AND PERICARDITIS CAN OCCUR FOLLOWING VACCINATION WITH NUVAXOVID
* EMA SAYS PRAC RECOMMENDING LISTING MYOCARDITIS AND PERICARDITIS AS NEW SIDE EFFECTS IN PRODUCT INFORMATION FOR NUVAXOVID * EMA: PRAC HAS ALSO REQUESTED THAT MARKETING AUTHORISATION HOLDER OF NUVAXOVID PROVIDES ADDITIONAL DATA ON RISK OF SIDE EFFECTS OCCURRING Source text for Eikon: Further company coverage:
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
In May, Americans received two checks from Social Security, indicating a fluctuating monthly distribution of…
The interview for food stamps is a crucial session to ensure eligibility and ensure proper…
In recent years, Home Depot has been a leading supplier of LED decorations, particularly for…
VA Veterans Affairs offers disability payments to veterans with an 80% VA disability rating, covering…
Tacoma, Washington, is receiving a $500 stimulus payment to help residents with rising incomes, addressing…
In the modern world, robust passports provide bearers advantages in international diplomacy, reflecting a country's…